Physician

Kevin R Brough, MD

According to 2025 Medicare claims, Kevin Brough, MD (NPI: 1326484999) practices micrographic dermatologic surgery in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is HEARTLAND DERMATOLOGY AND SKIN CANCER CENTER, PA (NPI: 1538135207; TIN: 481145139) and primary practice location at 67226-2160.

Brough's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,333 traditional Medicare patients, billed 8,047 HCPCS/CPT codes, and received $1,793,803 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,381 prescription claims across 989 beneficiaries totaling $9,119 in drug costs, led by Cefadroxil (Cefadroxil). Open Payments data shows 97 records totaling $1,988. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $4,415 to $1,793,803. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $36,741 and ending at $9,119. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	49	70	$4,415
2016	120	321	$12,235
2017	306	1,211	$35,089
2018	70	298	$7,472
2019	158	609	$16,063
2020	472	2,138	$571,467
2021	1,055	5,259	$1,368,685
2022	1,185	6,938	$1,469,704
2023	1,371	8,066	$1,738,808
2024	1,333	8,047	$1,793,803

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	82	481	$36,741
2016	94	601	$36,127
2017	114	279	$22,426
2018	160	291	$20,868
2019	195	458	$56,072
2020	290	444	$48,472
2021	705	1,073	$85,510
2022	902	1,391	$13,137
2023	959	1,433	$11,261
2024	989	1,381	$9,119

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	1,155	1,607	$392
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	753	1,234	$305
13132	Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm	503	529	$179
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	542	637	$66
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	949	1,227	$38

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cefadroxil	Cefadroxil	744	5,194	$3,980
Gentamicin Sulfate	Gentamicin Sulfate	29	842	$1,392
Clindamycin Hcl	Clindamycin Hcl	164	1,177	$1,133
Mupirocin	Mupirocin	85	1,916	$650
Doxycycline Hyclate	Doxycycline Hyclate	60	495	$539

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	97	$1,988	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin R. Brough, MD?

Tedicare shows public-source Medicare data for Kevin R. Brough, MD (NPI 1326484999), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin R. Brough, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kevin R. Brough, MD?

Kevin R. Brough, MD is linked to HEARTLAND DERMATOLOGY AND SKIN CANCER CENTER, PA (billing NPI 1538135207) in the available physician profile data.

Does Kevin R. Brough, MD have Open Payments data?

Kevin R. Brough, MD has 97 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.